APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Skin Patch

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Transdermal Skin Patch Market Analysis and Forecast 2026-2032

26 December 2025194 pages

Choose your research edition.

Industry ResearchTransdermal Skin Patch Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Skin Patch Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Transdermal Skin Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Skin Patch Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Skin Patch Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Transdermal Skin Patch market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Transdermal Skin Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Transdermal Skin Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Transdermal Skin Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Transdermal Skin Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Transdermal Skin Patch include Actavis, Changzhou Siyao, Henan Lingrui Pharmaceutical, Hisamitsu Pharmaceutical, Luye Pharma Group Ltd., Mundipharma, Purdue Pharma L.P., Rfl Pharmaceutical and Teikoku Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Transdermal Skin Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Transdermal Skin Patch, also provides the sales of main regions and countries. Of the upcoming market potential for Transdermal Skin Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transdermal Skin Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Transdermal Skin Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Transdermal Skin Patch sales, projected growth trends, production technology, application and end-user industry.

Transdermal Skin Patch Segment by Company

Actavis

Changzhou Siyao

Henan Lingrui Pharmaceutical

Hisamitsu Pharmaceutical

Luye Pharma Group Ltd.

Mundipharma

Purdue Pharma L.P.

Rfl Pharmaceutical

Teikoku Pharma

Mylan

Novartis

Johnson & Johnson

Teva Pharmaceutical Industries Ltd.

Transdermal Skin Patch Segment by Type

Buprenorphine Transdermal Skin Patch

Fentanyl Transdermal Skin Patch

Clonidine Transdermal Skin Patch

Nicotine Transdermal Skin Patch

Transdermal Skin Patch Segment by Application

Relieve Severe Pain

Stop Smoking Cigarettes

Treat an Overactive Bladder

Others

Transdermal Skin Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Skin Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Skin Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Skin Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Transdermal Skin Patch in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Transdermal Skin Patch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transdermal Skin Patch sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transdermal Skin Patch Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Buprenorphine Transdermal Skin Patch Major Manufacturers Table 3. Fentanyl Transdermal Skin Patch Major Manufacturers Table 4. Clonidine Transdermal Skin Patch Major Manufacturers Table 5. Nicotine Transdermal Skin Patch Major Manufacturers Table 6. Global Transdermal Skin Patch Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Relieve Severe Pain Major Manufacturers Table 8. Stop Smoking Cigarettes Major Manufacturers Table 9. Treat an Overactive Bladder Major Manufacturers Table 10. Others Major Manufacturers Table 11. Transdermal Skin Patch Industry Trends Table 12. Transdermal Skin Patch Industry Drivers Table 13. Transdermal Skin Patch Industry Opportunities and Challenges Table 14. Transdermal Skin Patch Industry Restraints Table 15. Global Transdermal Skin Patch Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Transdermal Skin Patch Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Transdermal Skin Patch Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Transdermal Skin Patch Revenue Market Share by Region (2021-2026) Table 19. Global Transdermal Skin Patch Revenue Market Share by Region (2027-2032) Table 20. Global Transdermal Skin Patch Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 21. Global Transdermal Skin Patch Sales by Region (2021-2026) & (W Units) Table 22. Global Transdermal Skin Patch Sales by Region (2027-2032) & (W Units) Table 23. Global Transdermal Skin Patch Sales Market Share by Region (2021-2026) Table 24. Global Transdermal Skin Patch Sales Market Share by Region (2027-2032) Table 25. Global Transdermal Skin Patch Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Transdermal Skin Patch Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Transdermal Skin Patch Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Transdermal Skin Patch Sales Market Share by Manufacturers (2021-2026) Table 29. Global Transdermal Skin Patch Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Transdermal Skin Patch Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Transdermal Skin Patch Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Transdermal Skin Patch Manufacturers, Product Type & Application Table 33. Global Transdermal Skin Patch Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Transdermal Skin Patch by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Transdermal Skin Patch Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Transdermal Skin Patch Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Transdermal Skin Patch Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Transdermal Skin Patch Revenue Market Share by Type (2021-2026) Table 40. Global Transdermal Skin Patch Revenue Market Share by Type (2027-2032) Table 41. Global Transdermal Skin Patch Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 42. Global Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 43. Global Transdermal Skin Patch Sales by Type (2027-2032) & (W Units) Table 44. Global Transdermal Skin Patch Sales Market Share by Type (2021-2026) Table 45. Global Transdermal Skin Patch Sales Market Share by Type (2027-2032) Table 46. Global Transdermal Skin Patch Price by Type (2021-2026) & (US$/Unit) Table 47. Global Transdermal Skin Patch Price by Type (2027-2032) & (US$/Unit) Table 48. Global Transdermal Skin Patch Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Transdermal Skin Patch Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Transdermal Skin Patch Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Transdermal Skin Patch Revenue Market Share by Application (2021-2026) Table 52. Global Transdermal Skin Patch Revenue Market Share by Application (2027-2032) Table 53. Global Transdermal Skin Patch Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 54. Global Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 55. Global Transdermal Skin Patch Sales by Application (2027-2032) & (W Units) Table 56. Global Transdermal Skin Patch Sales Market Share by Application (2021-2026) Table 57. Global Transdermal Skin Patch Sales Market Share by Application (2027-2032) Table 58. Global Transdermal Skin Patch Price by Application (2021-2026) & (US$/Unit) Table 59. Global Transdermal Skin Patch Price by Application (2027-2032) & (US$/Unit) Table 60. Actavis Company Information Table 61. Actavis Business Overview Table 62. Actavis Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Actavis Transdermal Skin Patch Product Portfolio Table 64. Actavis Recent Development Table 65. Changzhou Siyao Company Information Table 66. Changzhou Siyao Business Overview Table 67. Changzhou Siyao Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Changzhou Siyao Transdermal Skin Patch Product Portfolio Table 69. Changzhou Siyao Recent Development Table 70. Henan Lingrui Pharmaceutical Company Information Table 71. Henan Lingrui Pharmaceutical Business Overview Table 72. Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio Table 74. Henan Lingrui Pharmaceutical Recent Development Table 75. Hisamitsu Pharmaceutical Company Information Table 76. Hisamitsu Pharmaceutical Business Overview Table 77. Hisamitsu Pharmaceutical Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio Table 79. Hisamitsu Pharmaceutical Recent Development Table 80. Luye Pharma Group Ltd. Company Information Table 81. Luye Pharma Group Ltd. Business Overview Table 82. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio Table 84. Luye Pharma Group Ltd. Recent Development Table 85. Mundipharma Company Information Table 86. Mundipharma Business Overview Table 87. Mundipharma Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Mundipharma Transdermal Skin Patch Product Portfolio Table 89. Mundipharma Recent Development Table 90. Purdue Pharma L.P. Company Information Table 91. Purdue Pharma L.P. Business Overview Table 92. Purdue Pharma L.P. Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio Table 94. Purdue Pharma L.P. Recent Development Table 95. Rfl Pharmaceutical Company Information Table 96. Rfl Pharmaceutical Business Overview Table 97. Rfl Pharmaceutical Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio Table 99. Rfl Pharmaceutical Recent Development Table 100. Teikoku Pharma Company Information Table 101. Teikoku Pharma Business Overview Table 102. Teikoku Pharma Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Teikoku Pharma Transdermal Skin Patch Product Portfolio Table 104. Teikoku Pharma Recent Development Table 105. Mylan Company Information Table 106. Mylan Business Overview Table 107. Mylan Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Mylan Transdermal Skin Patch Product Portfolio Table 109. Mylan Recent Development Table 110. Novartis Company Information Table 111. Novartis Business Overview Table 112. Novartis Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Novartis Transdermal Skin Patch Product Portfolio Table 114. Novartis Recent Development Table 115. Johnson & Johnson Company Information Table 116. Johnson & Johnson Business Overview Table 117. Johnson & Johnson Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Johnson & Johnson Transdermal Skin Patch Product Portfolio Table 119. Johnson & Johnson Recent Development Table 120. Teva Pharmaceutical Industries Ltd. Company Information Table 121. Teva Pharmaceutical Industries Ltd. Business Overview Table 122. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio Table 124. Teva Pharmaceutical Industries Ltd. Recent Development Table 125. North America Transdermal Skin Patch Revenue by Type (2021-2026) & (US$ Million) Table 126. North America Transdermal Skin Patch Revenue by Type (2027-2032) & (US$ Million) Table 127. North America Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 128. North America Transdermal Skin Patch Sales by Type (2027-2032) & (W Units) Table 129. North America Transdermal Skin Patch Sales Price by Type (2021-2026) & (US$/Unit) Table 130. North America Transdermal Skin Patch Sales Price by Type (2027-2032) & (US$/Unit) Table 131. North America Transdermal Skin Patch Revenue by Application (2021-2026) & (US$ Million) Table 132. North America Transdermal Skin Patch Revenue by Application (2027-2032) & (US$ Million) Table 133. North America Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 134. North America Transdermal Skin Patch Sales by Application (2027-2032) & (W Units) Table 135. North America Transdermal Skin Patch Sales Price by Application (2021-2026) & (US$/Unit) Table 136. North America Transdermal Skin Patch Sales Price by Application (2027-2032) & (US$/Unit) Table 137. North America Transdermal Skin Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. North America Transdermal Skin Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. North America Transdermal Skin Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. North America Transdermal Skin Patch Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 141. North America Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 142. North America Transdermal Skin Patch Sales by Country (2027-2032) & (W Units) Table 143. North America Transdermal Skin Patch Sales Price by Country (2021-2026) & (US$/Unit) Table 144. North America Transdermal Skin Patch Sales Price by Country (2027-2032) & (US$/Unit) Table 145. United States Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 146. Canada Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 147. Mexico Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 148. Europe Transdermal Skin Patch Revenue by Type (2021-2026) & (US$ Million) Table 149. Europe Transdermal Skin Patch Revenue by Type (2027-2032) & (US$ Million) Table 150. Europe Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 151. Europe Transdermal Skin Patch Sales by Type (2027-2032) & (W Units) Table 152. Europe Transdermal Skin Patch Sales Price by Type (2021-2026) & (US$/Unit) Table 153. Europe Transdermal Skin Patch Sales Price by Type (2027-2032) & (US$/Unit) Table 154. Europe Transdermal Skin Patch Revenue by Application (2021-2026) & (US$ Million) Table 155. Europe Transdermal Skin Patch Revenue by Application (2027-2032) & (US$ Million) Table 156. Europe Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 157. Europe Transdermal Skin Patch Sales by Application (2027-2032) & (W Units) Table 158. Europe Transdermal Skin Patch Sales Price by Application (2021-2026) & (US$/Unit) Table 159. Europe Transdermal Skin Patch Sales Price by Application (2027-2032) & (US$/Unit) Table 160. Europe Transdermal Skin Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Europe Transdermal Skin Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. Europe Transdermal Skin Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. Europe Transdermal Skin Patch Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 164. Europe Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 165. Europe Transdermal Skin Patch Sales by Country (2027-2032) & (W Units) Table 166. Europe Transdermal Skin Patch Sales Price by Country (2021-2026) & (US$/Unit) Table 167. Europe Transdermal Skin Patch Sales Price by Country (2027-2032) & (US$/Unit) Table 168. Germany Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 169. France Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 170. U.K. Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 171. Italy Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 172. Russia Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 173. Spain Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 174. Netherlands Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 175. Switzerland Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 176. Sweden Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 177. Poland Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 178. China Transdermal Skin Patch Revenue by Type (2021-2026) & (US$ Million) Table 179. China Transdermal Skin Patch Revenue by Type (2027-2032) & (US$ Million) Table 180. China Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 181. China Transdermal Skin Patch Sales by Type (2027-2032) & (W Units) Table 182. China Transdermal Skin Patch Sales Price by Type (2021-2026) & (US$/Unit) Table 183. China Transdermal Skin Patch Sales Price by Type (2027-2032) & (US$/Unit) Table 184. China Transdermal Skin Patch Revenue by Application (2021-2026) & (US$ Million) Table 185. China Transdermal Skin Patch Revenue by Application (2027-2032) & (US$ Million) Table 186. China Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 187. China Transdermal Skin Patch Sales by Application (2027-2032) & (W Units) Table 188. China Transdermal Skin Patch Sales Price by Application (2021-2026) & (US$/Unit) Table 189. China Transdermal Skin Patch Sales Price by Application (2027-2032) & (US$/Unit) Table 190. Asia Transdermal Skin Patch Revenue by Type (2021-2026) & (US$ Million) Table 191. Asia Transdermal Skin Patch Revenue by Type (2027-2032) & (US$ Million) Table 192. Asia Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 193. Asia Transdermal Skin Patch Sales by Type (2027-2032) & (W Units) Table 194. Asia Transdermal Skin Patch Sales Price by Type (2021-2026) & (US$/Unit) Table 195. Asia Transdermal Skin Patch Sales Price by Type (2027-2032) & (US$/Unit) Table 196. Asia Transdermal Skin Patch Revenue by Application (2021-2026) & (US$ Million) Table 197. Asia Transdermal Skin Patch Revenue by Application (2027-2032) & (US$ Million) Table 198. Asia Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 199. Asia Transdermal Skin Patch Sales by Application (2027-2032) & (W Units) Table 200. Asia Transdermal Skin Patch Sales Price by Application (2021-2026) & (US$/Unit) Table 201. Asia Transdermal Skin Patch Sales Price by Application (2027-2032) & (US$/Unit) Table 202. Asia Transdermal Skin Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. Asia Transdermal Skin Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. Asia Transdermal Skin Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. Asia Transdermal Skin Patch Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 206. Asia Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 207. Asia Transdermal Skin Patch Sales by Country (2027-2032) & (W Units) Table 208. Asia Transdermal Skin Patch Sales Price by Country (2021-2026) & (US$/Unit) Table 209. Asia Transdermal Skin Patch Sales Price by Country (2027-2032) & (US$/Unit) Table 210. Japan Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 211. South Korea Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 212. India Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 213. Australia Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 214. Taiwan Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 215. Southeast Asia Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 216. SAMEA Transdermal Skin Patch Revenue by Type (2021-2026) & (US$ Million) Table 217. SAMEA Transdermal Skin Patch Revenue by Type (2027-2032) & (US$ Million) Table 218. SAMEA Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 219. SAMEA Transdermal Skin Patch Sales by Type (2027-2032) & (W Units) Table 220. SAMEA Transdermal Skin Patch Sales Price by Type (2021-2026) & (US$/Unit) Table 221. SAMEA Transdermal Skin Patch Sales Price by Type (2027-2032) & (US$/Unit) Table 222. SAMEA Transdermal Skin Patch Revenue by Application (2021-2026) & (US$ Million) Table 223. SAMEA Transdermal Skin Patch Revenue by Application (2027-2032) & (US$ Million) Table 224. SAMEA Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 225. SAMEA Transdermal Skin Patch Sales by Application (2027-2032) & (W Units) Table 226. SAMEA Transdermal Skin Patch Sales Price by Application (2021-2026) & (US$/Unit) Table 227. SAMEA Transdermal Skin Patch Sales Price by Application (2027-2032) & (US$/Unit) Table 228. SAMEA Transdermal Skin Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. SAMEA Transdermal Skin Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. SAMEA Transdermal Skin Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. SAMEA Transdermal Skin Patch Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 232. SAMEA Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 233. SAMEA Transdermal Skin Patch Sales by Country (2027-2032) & (W Units) Table 234. SAMEA Transdermal Skin Patch Sales Price by Country (2021-2026) & (US$/Unit) Table 235. SAMEA Transdermal Skin Patch Sales Price by Country (2027-2032) & (US$/Unit) Table 236. Brazil Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 237. Argentina Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 238. Chile Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 239. Colombia Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 240. Peru Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 241. Saudi Arabia Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 242. Israel Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 243. UAE Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 244. Turkey Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 245. Iran Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 246. Egypt Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Table 247. Key Raw Materials Table 248. Raw Materials Key Suppliers Table 249. Transdermal Skin Patch Distributors List Table 250. Transdermal Skin Patch Customers List Table 251. Research Programs/Design for This Report Table 252. Authors List of This Report Table 253. Secondary Sources Table 254. Primary Sources List of Figures Figure 1. Transdermal Skin Patch Image Figure 2. Global Transdermal Skin Patch Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Skin Patch Market Size Share 2021 VS 2025 VS 2032 Figure 4. Buprenorphine Transdermal Skin Patch Image Figure 5. Fentanyl Transdermal Skin Patch Image Figure 6. Clonidine Transdermal Skin Patch Image Figure 7. Nicotine Transdermal Skin Patch Image Figure 8. Global Transdermal Skin Patch Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Transdermal Skin Patch Market Size Share 2021 VS 2025 VS 2032 Figure 10. Relieve Severe Pain Image Figure 11. Stop Smoking Cigarettes Image Figure 12. Treat an Overactive Bladder Image Figure 13. Others Image Figure 14. Global Transdermal Skin Patch Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Transdermal Skin Patch Revenue (2021-2032) & (US$ Million) Figure 16. Global Transdermal Skin Patch Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Transdermal Skin Patch Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Transdermal Skin Patch Revenue Market Share by Region (2021-2032) Figure 19. Global Transdermal Skin Patch Sales (2021-2032) & (W Units) Figure 20. Global Transdermal Skin Patch Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 21. Global Transdermal Skin Patch Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Transdermal Skin Patch Sales YoY (2021-2032) & (W Units) Figure 23. Europe Transdermal Skin Patch Sales YoY (2021-2032) & (W Units) Figure 24. China Transdermal Skin Patch Sales YoY (2021-2032) & (W Units) Figure 25. Asia (Excluding China) Transdermal Skin Patch Sales YoY (2021-2032) & (W Units) Figure 26. South America, Middle East and Africa Transdermal Skin Patch Sales YoY (2021-2032) & (W Units) Figure 27. Global Transdermal Skin Patch Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Transdermal Skin Patch Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Transdermal Skin Patch Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Transdermal Skin Patch Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Transdermal Skin Patch Revenue Market Share by Type (2021-2032) Figure 33. Global Transdermal Skin Patch Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 34. Global Transdermal Skin Patch Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Transdermal Skin Patch Sales Market Share by Type (2021-2032) Figure 36. Global Transdermal Skin Patch Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Transdermal Skin Patch Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Transdermal Skin Patch Revenue Market Share by Application (2021-2032) Figure 39. Global Transdermal Skin Patch Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 40. Global Transdermal Skin Patch Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Transdermal Skin Patch Sales Market Share by Application (2021-2032) Figure 42. North America Transdermal Skin Patch Revenue Share by Type (2021-2032) Figure 43. North America Transdermal Skin Patch Sales Share by Type (2021-2032) Figure 44. North America Transdermal Skin Patch Revenue Share by Application (2021-2032) Figure 45. North America Transdermal Skin Patch Sales Share by Application (2021-2032) Figure 46. North America Transdermal Skin Patch Revenue Share by Country (2021-2032) Figure 47. North America Transdermal Skin Patch Sales Share by Country (2021-2032) Figure 48. Europe Transdermal Skin Patch Revenue Share by Type (2021-2032) Figure 49. Europe Transdermal Skin Patch Sales Share by Type (2021-2032) Figure 50. Europe Transdermal Skin Patch Revenue Share by Application (2021-2032) Figure 51. Europe Transdermal Skin Patch Sales Share by Application (2021-2032) Figure 52. Europe Transdermal Skin Patch Revenue Share by Country (2021-2032) Figure 53. Europe Transdermal Skin Patch Sales Share by Country (2021-2032) Figure 54. China Transdermal Skin Patch Revenue Share by Type (2021-2032) Figure 55. China Transdermal Skin Patch Sales Share by Type (2021-2032) Figure 56. China Transdermal Skin Patch Revenue Share by Application (2021-2032) Figure 57. China Transdermal Skin Patch Sales Share by Application (2021-2032) Figure 58. Asia Transdermal Skin Patch Revenue Share by Type (2021-2032) Figure 59. Asia Transdermal Skin Patch Sales Share by Type (2021-2032) Figure 60. Asia Transdermal Skin Patch Revenue Share by Application (2021-2032) Figure 61. Asia Transdermal Skin Patch Sales Share by Application (2021-2032) Figure 62. Asia Transdermal Skin Patch Revenue Share by Country (2021-2032) Figure 63. Asia Transdermal Skin Patch Sales Share by Country (2021-2032) Figure 64. SAMEA Transdermal Skin Patch Revenue Share by Type (2021-2032) Figure 65. SAMEA Transdermal Skin Patch Sales Share by Type (2021-2032) Figure 66. SAMEA Transdermal Skin Patch Revenue Share by Application (2021-2032) Figure 67. SAMEA Transdermal Skin Patch Sales Share by Application (2021-2032) Figure 68. SAMEA Transdermal Skin Patch Revenue Share by Country (2021-2032) Figure 69. SAMEA Transdermal Skin Patch Sales Share by Country (2021-2032) Figure 70. Transdermal Skin Patch Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Transdermal Skin Patch Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Buprenorphine Transdermal Skin Patch
  • Fentanyl Transdermal Skin Patch
  • Clonidine Transdermal Skin Patch
  • Nicotine Transdermal Skin Patch
Applications
  • Relieve Severe Pain
  • Stop Smoking Cigarettes
  • Treat an Overactive Bladder
  • Others
Companies covered
  • Actavis
  • Changzhou Siyao
  • Henan Lingrui Pharmaceutical
  • Hisamitsu Pharmaceutical
  • Luye Pharma Group Ltd.
  • Mundipharma
  • Purdue Pharma L.P.
  • Rfl Pharmaceutical
  • Teikoku Pharma
  • Mylan
  • Novartis
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Transdermal Skin Patch Market by Type
  3. 1.2.1 Global Transdermal Skin Patch Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Buprenorphine Transdermal Skin Patch
  5. 1.2.3 Fentanyl Transdermal Skin Patch
  6. 1.2.4 Clonidine Transdermal Skin Patch
  7. 1.2.5 Nicotine Transdermal Skin Patch
  8. 1.3 Transdermal Skin Patch Market by Application
  9. 1.3.1 Global Transdermal Skin Patch Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Relieve Severe Pain
  11. 1.3.3 Stop Smoking Cigarettes
  12. 1.3.4 Treat an Overactive Bladder
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Transdermal Skin Patch Market Dynamics
  1. 2.1 Transdermal Skin Patch Industry Trends
  2. 2.2 Transdermal Skin Patch Industry Drivers
  3. 2.3 Transdermal Skin Patch Industry Opportunities and Challenges
  4. 2.4 Transdermal Skin Patch Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Transdermal Skin Patch Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Transdermal Skin Patch Revenue by Region
  3. 3.2.1 Global Transdermal Skin Patch Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Transdermal Skin Patch Revenue by Region (2021-2026)
  5. 3.2.3 Global Transdermal Skin Patch Revenue by Region (2027-2032)
  6. 3.2.4 Global Transdermal Skin Patch Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Transdermal Skin Patch Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Transdermal Skin Patch Sales by Region
  9. 3.4.1 Global Transdermal Skin Patch Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Transdermal Skin Patch Sales by Region (2021-2026)
  11. 3.4.3 Global Transdermal Skin Patch Sales by Region (2027-2032)
  12. 3.4.4 Global Transdermal Skin Patch Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Transdermal Skin Patch Revenue by Manufacturers
  2. 4.1.1 Global Transdermal Skin Patch Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Transdermal Skin Patch Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Transdermal Skin Patch Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Transdermal Skin Patch Sales by Manufacturers
  6. 4.2.1 Global Transdermal Skin Patch Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Transdermal Skin Patch Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Transdermal Skin Patch Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Transdermal Skin Patch Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Transdermal Skin Patch Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Transdermal Skin Patch Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Transdermal Skin Patch Manufacturers, Product Type & Application
  13. 4.7 Global Transdermal Skin Patch Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Transdermal Skin Patch Market CR5 and HHI
  16. 4.8.2 2025 Transdermal Skin Patch Tier 1, Tier 2, and Tier 3
5 Transdermal Skin Patch Market by Type
  1. 5.1 Global Transdermal Skin Patch Revenue by Type
  2. 5.1.1 Global Transdermal Skin Patch Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Transdermal Skin Patch Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Transdermal Skin Patch Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Transdermal Skin Patch Sales by Type
  6. 5.2.1 Global Transdermal Skin Patch Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Transdermal Skin Patch Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Transdermal Skin Patch Sales Market Share by Type (2021-2032)
  9. 5.3 Global Transdermal Skin Patch Price by Type
6 Transdermal Skin Patch Market by Application
  1. 6.1 Global Transdermal Skin Patch Revenue by Application
  2. 6.1.1 Global Transdermal Skin Patch Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Transdermal Skin Patch Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Transdermal Skin Patch Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Transdermal Skin Patch Sales by Application
  6. 6.2.1 Global Transdermal Skin Patch Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Transdermal Skin Patch Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Transdermal Skin Patch Sales Market Share by Application (2021-2032)
  9. 6.3 Global Transdermal Skin Patch Price by Application
7 Company Profiles
  1. 7.1 Actavis
  2. 7.1.1 Actavis Company Information
  3. 7.1.2 Actavis Business Overview
  4. 7.1.3 Actavis Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Actavis Transdermal Skin Patch Product Portfolio
  6. 7.1.5 Actavis Recent Developments
  7. 7.2 Changzhou Siyao
  8. 7.2.1 Changzhou Siyao Company Information
  9. 7.2.2 Changzhou Siyao Business Overview
  10. 7.2.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Changzhou Siyao Transdermal Skin Patch Product Portfolio
  12. 7.2.5 Changzhou Siyao Recent Developments
  13. 7.3 Henan Lingrui Pharmaceutical
  14. 7.3.1 Henan Lingrui Pharmaceutical Company Information
  15. 7.3.2 Henan Lingrui Pharmaceutical Business Overview
  16. 7.3.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio
  18. 7.3.5 Henan Lingrui Pharmaceutical Recent Developments
  19. 7.4 Hisamitsu Pharmaceutical
  20. 7.4.1 Hisamitsu Pharmaceutical Company Information
  21. 7.4.2 Hisamitsu Pharmaceutical Business Overview
  22. 7.4.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio
  24. 7.4.5 Hisamitsu Pharmaceutical Recent Developments
  25. 7.5 Luye Pharma Group Ltd.
  26. 7.5.1 Luye Pharma Group Ltd. Company Information
  27. 7.5.2 Luye Pharma Group Ltd. Business Overview
  28. 7.5.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio
  30. 7.5.5 Luye Pharma Group Ltd. Recent Developments
  31. 7.6 Mundipharma
  32. 7.6.1 Mundipharma Company Information
  33. 7.6.2 Mundipharma Business Overview
  34. 7.6.3 Mundipharma Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mundipharma Transdermal Skin Patch Product Portfolio
  36. 7.6.5 Mundipharma Recent Developments
  37. 7.7 Purdue Pharma L.P.
  38. 7.7.1 Purdue Pharma L.P. Company Information
  39. 7.7.2 Purdue Pharma L.P. Business Overview
  40. 7.7.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio
  42. 7.7.5 Purdue Pharma L.P. Recent Developments
  43. 7.8 Rfl Pharmaceutical
  44. 7.8.1 Rfl Pharmaceutical Company Information
  45. 7.8.2 Rfl Pharmaceutical Business Overview
  46. 7.8.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio
  48. 7.8.5 Rfl Pharmaceutical Recent Developments
  49. 7.9 Teikoku Pharma
  50. 7.9.1 Teikoku Pharma Company Information
  51. 7.9.2 Teikoku Pharma Business Overview
  52. 7.9.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Teikoku Pharma Transdermal Skin Patch Product Portfolio
  54. 7.9.5 Teikoku Pharma Recent Developments
  55. 7.10 Mylan
  56. 7.10.1 Mylan Company Information
  57. 7.10.2 Mylan Business Overview
  58. 7.10.3 Mylan Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Mylan Transdermal Skin Patch Product Portfolio
  60. 7.10.5 Mylan Recent Developments
  61. 7.11 Novartis
  62. 7.11.1 Novartis Company Information
  63. 7.11.2 Novartis Business Overview
  64. 7.11.3 Novartis Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Novartis Transdermal Skin Patch Product Portfolio
  66. 7.11.5 Novartis Recent Developments
  67. 7.12 Johnson & Johnson
  68. 7.12.1 Johnson & Johnson Company Information
  69. 7.12.2 Johnson & Johnson Business Overview
  70. 7.12.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Johnson & Johnson Transdermal Skin Patch Product Portfolio
  72. 7.12.5 Johnson & Johnson Recent Developments
  73. 7.13 Teva Pharmaceutical Industries Ltd.
  74. 7.13.1 Teva Pharmaceutical Industries Ltd. Company Information
  75. 7.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
  76. 7.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio
  78. 7.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
8 North America
  1. 8.1 North America Transdermal Skin Patch Market Size by Type
  2. 8.1.1 North America Transdermal Skin Patch Revenue by Type (2021-2032)
  3. 8.1.2 North America Transdermal Skin Patch Sales by Type (2021-2032)
  4. 8.1.3 North America Transdermal Skin Patch Price by Type (2021-2032)
  5. 8.2 North America Transdermal Skin Patch Market Size by Application
  6. 8.2.1 North America Transdermal Skin Patch Revenue by Application (2021-2032)
  7. 8.2.2 North America Transdermal Skin Patch Sales by Application (2021-2032)
  8. 8.2.3 North America Transdermal Skin Patch Price by Application (2021-2032)
  9. 8.3 North America Transdermal Skin Patch Market Size by Country
  10. 8.3.1 North America Transdermal Skin Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Transdermal Skin Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Transdermal Skin Patch Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Transdermal Skin Patch Market Size by Type
  2. 9.1.1 Europe Transdermal Skin Patch Revenue by Type (2021-2032)
  3. 9.1.2 Europe Transdermal Skin Patch Sales by Type (2021-2032)
  4. 9.1.3 Europe Transdermal Skin Patch Price by Type (2021-2032)
  5. 9.2 Europe Transdermal Skin Patch Market Size by Application
  6. 9.2.1 Europe Transdermal Skin Patch Revenue by Application (2021-2032)
  7. 9.2.2 Europe Transdermal Skin Patch Sales by Application (2021-2032)
  8. 9.2.3 Europe Transdermal Skin Patch Price by Application (2021-2032)
  9. 9.3 Europe Transdermal Skin Patch Market Size by Country
  10. 9.3.1 Europe Transdermal Skin Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Transdermal Skin Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Transdermal Skin Patch Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Transdermal Skin Patch Market Size by Type
  2. 10.1.1 China Transdermal Skin Patch Revenue by Type (2021-2032)
  3. 10.1.2 China Transdermal Skin Patch Sales by Type (2021-2032)
  4. 10.1.3 China Transdermal Skin Patch Price by Type (2021-2032)
  5. 10.2 China Transdermal Skin Patch Market Size by Application
  6. 10.2.1 China Transdermal Skin Patch Revenue by Application (2021-2032)
  7. 10.2.2 China Transdermal Skin Patch Sales by Application (2021-2032)
  8. 10.2.3 China Transdermal Skin Patch Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Transdermal Skin Patch Market Size by Type
  2. 11.1.1 Asia Transdermal Skin Patch Revenue by Type (2021-2032)
  3. 11.1.2 Asia Transdermal Skin Patch Sales by Type (2021-2032)
  4. 11.1.3 Asia Transdermal Skin Patch Price by Type (2021-2032)
  5. 11.2 Asia Transdermal Skin Patch Market Size by Application
  6. 11.2.1 Asia Transdermal Skin Patch Revenue by Application (2021-2032)
  7. 11.2.2 Asia Transdermal Skin Patch Sales by Application (2021-2032)
  8. 11.2.3 Asia Transdermal Skin Patch Price by Application (2021-2032)
  9. 11.3 Asia Transdermal Skin Patch Market Size by Country
  10. 11.3.1 Asia Transdermal Skin Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Transdermal Skin Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Transdermal Skin Patch Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Transdermal Skin Patch Market Size by Type
  2. 12.1.1 SAMEA Transdermal Skin Patch Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Transdermal Skin Patch Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Transdermal Skin Patch Price by Type (2021-2032)
  5. 12.2 SAMEA Transdermal Skin Patch Market Size by Application
  6. 12.2.1 SAMEA Transdermal Skin Patch Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Transdermal Skin Patch Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Transdermal Skin Patch Price by Application (2021-2032)
  9. 12.3 SAMEA Transdermal Skin Patch Market Size by Country
  10. 12.3.1 SAMEA Transdermal Skin Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Transdermal Skin Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Transdermal Skin Patch Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Transdermal Skin Patch Value Chain Analysis
  2. 13.1.1 Transdermal Skin Patch Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Transdermal Skin Patch Production Mode & Process
  6. 13.2 Transdermal Skin Patch Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Transdermal Skin Patch Distributors
  9. 13.2.3 Transdermal Skin Patch Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst